American Journal of Physiology-Lung Cellular and Molecular Physiology · 1997 · 50 citations · 0 references
Life SciencesNeurobiologyPharmacologyCell SignalingNeuropharmacologySignal TransductionCalcium SignalingCholinergic PharmacologyCholinergic SignalingIntracellular Calcium SignalingNeurotransmissionNeurotransmitter ReleaseCalcium Release From Intracellular StoresCholinergic Signal TransductionMuscarinic Acetylcholine Receptor SignalingMuscarinic AgonistsMuscarinic Receptor SubtypesMuscarinic ReceptorsNicotinic Acetylcholine Receptor AgonismReceptors
To examine cholinergic signal transduction pathways that modulate ciliary beat frequency (CBF), cultured ovine tracheal epithelial cells were imaged using a combination of phase-contrast (CBF) and fluorescence (Ca2+) microscopy techniques. In single cells, acetylcholine (ACh) transiently increased CBF and intracellular Ca2+ concentration ([Ca2+]i), mainly by Ca2+ release from internal stores, with a small delayed contribution from Ca2+ influx. Nicotinic agonists did not alter CBF or [Ca2+]i, whereas atropine blocked the ACh-stimulated transients, consistent with the involvement of muscarinic receptors. 4-Diphenylacetoxy-N-methylpiperidine methiodide was approximately 100 times more potent than pirenzepine in inhibiting the ACh-induced [Ca2+]i peaks, suggesting that the receptor is a pharmacologically defined (M3) subtype. Interestingly, after depletion of intracellular Ca2+ stores by thapsigargin, ACh caused a rapid transient decrease in both CBF and [Ca2+]i, again with an antagonist profile of M3 receptors. We conclude that activation of M3 muscarinic receptors initiates specific signaling pathways that act simultaneously to increase and decrease [Ca2+]i and CBF.